ストックスクリーナーアプリを入手
5.24
1.95%
-0.14
前日終値:
$5.38
開ける：
$5.35
24時間の取引高:
154.13K
Relative Volume:
0.21
時価総額：
$288.75M
収益：
$124.00K
当期純損益:
$-49.99M
株価収益率:
-3.1006
EPS:
-1.69
ネットキャッシュフロー:
$-31.03M
1週間 パフォーマンス:
-2.31%
1か月 パフォーマンス:
-5.13%
6か月 パフォーマンス:
-0.09%
1年 パフォーマンス:
-0.09%
1日の値動き範囲:
$5.26
$5.44
1週間の範囲:
$5.27
$5.85
52週間の値動き範囲:
$3.785
$14.60
Candel Therapeutics Inc Stock (CADL) Company Profile
CADL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CADL
Candel Therapeutics Inc
|
5.26 | 295.34M | 124.00K | -49.99M | -31.03M | -1.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
420.67 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
632.59 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.00 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
815.91 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
181.01 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Candel Therapeutics Inc Stock (CADL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-28 | 開始されました | Stephens | Overweight |
| 2025-09-03 | ダウングレード | BofA Securities | Buy → Neutral |
| 2025-06-30 | 再開されました | H.C. Wainwright | Buy |
| 2025-02-20 | 開始されました | Citigroup | Buy |
| 2025-02-19 | 開始されました | Canaccord Genuity | Buy |
| 2025-02-07 | 開始されました | BofA Securities | Buy |
| 2022-12-02 | 開始されました | H.C. Wainwright | Buy |
| 2021-11-19 | 開始されました | BMO Capital Markets | Outperform |
| 2021-08-23 | 開始されました | Credit Suisse | Outperform |
| 2021-08-23 | 開始されました | Jefferies | Buy |
| 2021-08-23 | 開始されました | UBS | Buy |
すべてを表示
Candel Therapeutics Inc (CADL) 最新ニュース
Candel Therapeutics, Inc. CEO Paul Peter Tak to Present at Jefferies Global Healthcare Conference 2025 - Quiver Quantitative
Nov 18: Candel Therapeutics (NASDAQ: CADL) to present at Jefferies Healthcare in London - Stock Titan
Will Candel Therapeutics Inc. see short term momentumJuly 2025 Volume & Capital Efficient Trading Techniques - newser.com
What technical models suggest about Candel Therapeutics Inc.’s comebackTrade Entry Report & Expert Curated Trade Setup Alerts - newser.com
How geopolitical tensions affect Candel Therapeutics Inc. stock2025 Biggest Moves & Free High Accuracy Swing Entry Alerts - newser.com
Will Candel Therapeutics Inc. stock reach all time highs in 2025Gap Up & Growth Focused Stock Reports - newser.com
Can volume confirm reversal in Candel Therapeutics Inc.Weekly Investment Recap & Free Growth Oriented Trading Recommendations - newser.com
How Candel Therapeutics Inc. stock performs in stagflationJuly 2025 Volume & Growth Focused Stock Reports - newser.com
Intraday pattern recognizer results for Candel Therapeutics Inc.2025 Risk Factors & Daily Chart Pattern Signals - newser.com
Can Candel Therapeutics Inc. stock weather global recession2025 Biggest Moves & Daily Risk Controlled Trade Plans - newser.com
What’s next for Candel Therapeutics Inc. stock priceOil Prices & Detailed Earnings Play Strategies - newser.com
What the charts say about Candel Therapeutics Inc. today2025 Institutional Moves & Real-Time Stock Movement Alerts - newser.com
Is Candel Therapeutics Inc. building a consolidation baseMarket Risk Summary & Entry Point Confirmation Alerts - newser.com
Why analysts upgrade Candel Therapeutics Inc. stockJuly 2025 Recap & Accurate Buy Signal Notifications - newser.com
How Candel Therapeutics Inc. stock compares to growth peersJuly 2025 Setups & Trade Opportunity Analysis Reports - newser.com
Will Candel Therapeutics Inc. stock outperform international peersJuly 2025 PostEarnings & Precise Buy Zone Identification - newser.com
Can Candel Therapeutics Inc. stock sustain revenue growthMarket Activity Report & Free Technical Confirmation Trade Alerts - newser.com
Will Candel Therapeutics Inc. stock benefit from automationLong Setup & Real-Time Stock Entry Alerts - newser.com
Candel Therapeutics, Inc. (CADL) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Candel Therapeutics, Inc. (CADL) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Candel Therapeutics (NASDAQ:CADL) Rating Increased to Strong-Buy at Stephens - MarketBeat
Candel Therapeutics Inc (CADL) 財務データ
収益
当期純利益
現金流量
EPS
0.66%
0.84%
大文字化:
|
ボリューム (24 時間):